Anthera Pharmaceuticals Stock Market Value
| ANTH Stock | USD 0.0001 0.00 0.00% |
| Symbol | Anthera |
Anthera Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Anthera Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Anthera Pharmaceuticals.
| 10/24/2025 |
| 01/22/2026 |
If you would invest 0.00 in Anthera Pharmaceuticals on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding Anthera Pharmaceuticals or generate 0.0% return on investment in Anthera Pharmaceuticals over 90 days. Anthera Pharmaceuticals is related to or competes with Marti Technologies, TIM Participacoes, C4 Therapeutics, MicroCloud Hologram, Immersion, Horizon Technology, and Liberty Live. Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicine... More
Anthera Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Anthera Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Anthera Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Anthera Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anthera Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Anthera Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Anthera Pharmaceuticals historical prices to predict the future Anthera Pharmaceuticals' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anthera Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anthera Pharmaceuticals Backtested Returns
We have found three technical indicators for Anthera Pharmaceuticals, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Anthera Pharmaceuticals are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Anthera Pharmaceuticals has perfect predictability. Overlapping area represents the amount of predictability between Anthera Pharmaceuticals time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Anthera Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current Anthera Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
Other Information on Investing in Anthera Pink Sheet
Anthera Pharmaceuticals financial ratios help investors to determine whether Anthera Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anthera with respect to the benefits of owning Anthera Pharmaceuticals security.